Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Drug Dealer, MD

How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop

(Autor)

Buch | Softcover
192 Seiten
2017
Johns Hopkins University Press (Verlag)
978-1-4214-2140-7 (ISBN)
CHF 28,80 inkl. MwSt
  • Titel z.Zt. nicht lieferbar
  • Portofrei ab CHF 40
  • Auch auf Rechnung
  • Artikel merken
Three out of four people addicted to heroin probably started on a prescription opioid, according to the director of the Centers for Disease Control and Prevention. In the United States alone, 16,000 people die each year as a result of prescription opioid overdose. But perhaps the most frightening aspect of the prescription drug epidemic is that it's built on well-meaning doctors treating patients with real problems. In Drug Dealer, MD, Dr. Anna Lembke uncovers the unseen forces driving opioid addiction nationwide. Combining case studies from her own practice with vital statistics drawn from public policy, cultural anthropology, and neuroscience, she explores the complex relationship between doctors and patients, the science of addiction, and the barriers to successfully addressing drug dependence and addiction. Even when addiction is recognized by doctors and their patients, she argues, many doctors don't know how to treat it, connections to treatment are lacking, and insurance companies won't pay for rehab.
Full of extensive interviews-with health care providers, pharmacists, social workers, hospital administrators, insurance company executives, journalists, economists, advocates, and patients and their families- Drug Dealer, MD, is for anyone whose life has been touched in some way by addiction to prescription drugs. Dr. Lembke gives voice to the millions of Americans struggling with prescription drugs while singling out the real culprits behind the rise in opioid addiction: cultural narratives that promote pills as quick fixes, pharmaceutical corporations in cahoots with organized medicine, and a new medical bureaucracy focused on the bottom line that favors pills, procedures, and patient satisfaction over wellness. Dr. Lembke concludes that the prescription drug epidemic is a symptom of a faltering health care system, the solution for which lies in rethinking how health care is delivered.

Anna Lembke, MD, is the chief of addiction medicine and an assistant professor at Stanford University School of Medicine.

Contents1. Introduction: The Prescription Drug Epidemic2. What is Addiction and Who's at Risk? 3. Pain is Dangerous, Difference is Psychopathology: The Role of Illness Narratives4. Big Pharma Joins Big Medicine, Co-Opting Medical Science to Promote Pill-Taking 5. The Drug-Seeking Patient: Malingering vs the Hijacked Brain 6. The Professional Patient: Illness as Identity and a Right to Be Compensated7. The Compassionate Doctor, the Narcissistic Injury, and the Primitive Defense8. Pill Mills and the Toyota-ization of Medicine 9. Addiction, the Disease Insurance Companies Still Won't Pay Doctors to Treat10. Stopping the Cycle of Compulsive Prescribing Bibliography

Erscheinungsdatum
Verlagsort Baltimore, MD
Sprache englisch
Maße 140 x 216 mm
Gewicht 249 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Medizinische Fachgebiete Suchtkrankheiten
Studium Querschnittsbereiche Prävention / Gesundheitsförderung
Sozialwissenschaften Soziologie
ISBN-10 1-4214-2140-2 / 1421421402
ISBN-13 978-1-4214-2140-7 / 9781421421407
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
das Manual zur psychologischen Gesundheitsförderung

von Gert Kaluza

Buch | Hardcover (2023)
Springer Berlin (Verlag)
CHF 55,95
Orthomolekulare Medizin in Prävention, Diagnostik und Therapie

von Volker Schmiedel

Buch | Hardcover (2022)
Thieme (Verlag)
CHF 81,80